Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial

Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial

Abstract Purpose Methylene blue (MB) has been tested as a rescue therapy for patients with refractory septic shock. However, there is a lack of evidence on MB as an adjuvant therapy, its’ optimal timing, dosing and safety profile. We aimed to assess whether early adjunctive MB can reduce time to vas...

Full description

Bibliographic Details
Main Authors: Miguel Ibarra-Estrada, Eduardo Kattan, Pavel Aguilera-González, Laura Sandoval-Plascencia, Uriel Rico-Jauregui, Carlos A. Gómez-Partida, Iris X. Ortiz-Macías, José A. López-Pulgarín, Quetzalcóatl Chávez-Peña, Julio C. Mijangos-Méndez, Guadalupe Aguirre-Avalos, Glenn Hernández
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Critical Care
Subjects:
Methylene blue
Randomized controlled trial
Septic shock
Norepinephrine
Vasopressin
Catecholamine sparing
Online Access:https://doi.org/10.1186/s13054-023-04397-7

Internet

https://doi.org/10.1186/s13054-023-04397-7

Similar Items